Clinical Trial Update: SOLFA Study to Explore the Thrombogenicity of a Dialyzer [NA]

View source ↗

Summary

The SOLFA study, sponsored by Fundación Senefro, completed its evaluation of the thrombogenicity of a dialyzer in patients with end-stage renal disease on dialy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Fundación Senefro | Conditions: End Stage Renal Disease on Dialysis | NA | Status: COMPLETED